trial
as of 2026-07-01Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
NCTId NCT02194933
at a glance
Phase 3 · Completed
Enrollment 38 (actual)
Primary completion 2016-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2015-02
Primary completion
2016-04
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Sites
1 total
Orange, United States
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
38
Phase
PHASE3
Primary Completion Date
2016-04
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication